• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Corrigendum to 'Microvesicle-associated tissue factor procoagulant activity for the preoperative diagnosis of ovarian cancer", [Thromb. Res. 141 (2016) 39-48].

作者信息

Claussen Carlota, Rausch Alma-Verena, Lezius Susanne, Amirkhosravi Ali, Davila Monica, Francis John L, Hisada Yohei M, Mackman Nigel, Bokemeyer Carsten, Schmalfeldt Barbara, Mahner Sven, Langer Florian

机构信息

II. Medizinische Klinik und Poliklinik, Onkologisches Zentrum, Universitäres Cancer Center Hamburg (UCCH), Universitätsklinikum Eppendorf, Martinistr 52, D-20246 Hamburg, Germany.

Klinik und Poliklinik für Gynäkologie, Zentrum für Operative Medizin, Universitätsklinikum Eppendorf, Martinistr 52, D-20246 Hamburg, Germany.

出版信息

Thromb Res. 2016 Oct;146:135. doi: 10.1016/j.thromres.2016.09.008. Epub 2016 Sep 16.

DOI:10.1016/j.thromres.2016.09.008
PMID:27640329
Abstract
摘要

相似文献

1
Corrigendum to 'Microvesicle-associated tissue factor procoagulant activity for the preoperative diagnosis of ovarian cancer", [Thromb. Res. 141 (2016) 39-48].
Thromb Res. 2016 Oct;146:135. doi: 10.1016/j.thromres.2016.09.008. Epub 2016 Sep 16.
2
Microvesicle-associated tissue factor procoagulant activity for the preoperative diagnosis of ovarian cancer.微泡相关组织因子促凝活性用于卵巢癌的术前诊断
Thromb Res. 2016 May;141:39-48. doi: 10.1016/j.thromres.2016.03.002. Epub 2016 Mar 2.
3
Corrigendum to "Measurement of microparticle tissue factor activity in clinical samples: A summary of two tissue factor-dependent FXa generation assays" [Thromb. Res. 139 (2016) 90-97].《临床样本中微粒组织因子活性的测定：两种组织因子依赖性FXa生成试验的总结》勘误 [《血栓研究》139 (2016) 90 - 97]
Thromb Res. 2016 Nov;147:63. doi: 10.1016/j.thromres.2016.09.009. Epub 2016 Sep 24.
4
Lysophosphatidic acid induces thrombogenic activity through phosphatidylserine exposure and procoagulant microvesicle generation in human erythrocytes.溶血磷脂酸通过人红细胞中磷脂酰丝氨酸的暴露和促凝微泡的产生诱导血栓形成活性。
Arterioscler Thromb Vasc Biol. 2007 Feb;27(2):414-21. doi: 10.1161/01.ATV.0000252898.48084.6a. Epub 2006 Nov 16.
5
Increased heparanase level and procoagulant activity in orthopedic surgery patients receiving prophylactic dose of enoxaparin.骨科手术患者预防性使用依诺肝素时，其肝素酶水平和促凝活性升高。
Thromb Res. 2012 Jul;130(1):129-34. doi: 10.1016/j.thromres.2011.09.021. Epub 2011 Dec 10.
6
Corrigendum to "Elevated plasma neutrophil elastase concentration is associated with disease activity in patients with thrombotic thrombocytopenic purpura" [Thromb. Res. 133 (2014) 616-621].
Thromb Res. 2016 May;141:145. doi: 10.1016/j.thromres.2016.03.023. Epub 2016 Apr 2.
7
Corrigendum to "Transplantation of VEGFl65-overexpressing vascular endothelial progenitor cells relieves endothelial injury after deep vein thrombectomy" [Thromb. Res. 137 (2016) 41-45].
Thromb Res. 2017 Jun;154:107. doi: 10.1016/j.thromres.2017.04.026. Epub 2017 May 7.
8
Corrigendum to "Effect of double-filtration plasmapheresis for antibody-mediated rejection on hemostasis parameters and thrombin generation" [Thromb. Res. 166 (2018) 113-121].
Thromb Res. 2018 Nov;171:200. doi: 10.1016/j.thromres.2018.05.033. Epub 2018 Jun 8.
9
Corrigendum to "Delayed time to emergency hip surgery in patients taking oral anticoagulants" [Thromb Res. 184 (2019 Dec) 110-114].
Thromb Res. 2020 Jan;185:183. doi: 10.1016/j.thromres.2019.12.001. Epub 2019 Dec 9.
10
Corrigendum to "Inhibitory effects of resveratrol on platelet activation and thrombosis in colon cancer through regulation of the MAPK and cGMP/VASP pathways" [Thromb. Res. 2024 Aug 2:241:109111].《白藜芦醇通过调节MAPK和cGMP/VASP途径对结肠癌血小板活化和血栓形成的抑制作用》的勘误[《血栓研究》2024年8月2日；241:109111]
Thromb Res. 2024 Oct;242:109131. doi: 10.1016/j.thromres.2024.109131. Epub 2024 Aug 29.